SCHEMBL25844668

SCHEMBL25844668

CCC1(CC)c2ccccc2-c2c1c1c(c3cc(OC)ccc23)OC(c2ccc(N3CCOCC3)cc2)(c2ccc(N3CCOCC3)cc2)C=C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.35
PIK3C3 Q8NEB9 2/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 4/20 0.32
HTR7 P34969 2/20 0.32
HSD17B10 Q99714 4/20 0.32
TSHR P16473 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ATM Q13315 2/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
TP53 P04637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25600300 0.99 RAB9A (0.35) ADAM17PIK3C3RAB9AL3MBTL1MAPT
SCHEMBL25844662 0.98 ADAM17 (0.34) ADAM17PIK3C3RAB9AL3MBTL1MAPT
SCHEMBL25600304 0.96 KMT2A (0.34) ADAM17PIK3C3RAB9AL3MBTL1MAPT
SCHEMBL25600434 0.96 RAB9A (0.35) ADAM17PIK3C3RAB9AMAPTHTR7
SCHEMBL25600438 0.96 RAB9A (0.35) ADAM17PIK3C3RAB9AMAPTHTR7
SCHEMBL25606852 0.95 MAPT (0.34) ADAM17RAB9AMAPTHTR7HSD17B10
SCHEMBL26627907 0.94 MAPT (0.33) ADAM17RAB9AMAPTHTR7HSD17B10
SCHEMBL26627990 0.94 RAB9A (0.36) ADAM17RAB9AL3MBTL1MAPTHTR7
SCHEMBL25600425 0.94 ADAM17 (0.36) ADAM17PIK3C3RAB9AL3MBTL1MAPT
SCHEMBL25600316 0.94 ATM (0.33) ADAM17PIK3C3ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4269532-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-11-01 EP disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 ADAM17 4791/4885PIK3C3 4793/4885RAB9A 1795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.